Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China
· Delayed Price · Currency is CNY 30.42
-0.90 (-2.87%)
Jun 5, 2025, 2:45 PM CST
SHE:002773 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 28,094 | 18,028 | 16,955 | 14,426 | 18,711 | 44,373 | Upgrade
|
| Market Cap Growth | 44.10% | 6.33% | 17.53% | -22.90% | -57.83% | 37.39% | Upgrade
|
| Enterprise Value | 22,012 | 12,488 | 12,473 | 11,281 | 15,524 | 42,323 | Upgrade
|
| Last Close Price | 29.90 | 19.60 | 18.13 | 15.32 | 19.73 | 46.48 | Upgrade
|
| PE Ratio | 23.07 | 15.13 | 16.23 | 16.09 | 44.44 | - | Upgrade
|
| Forward PE | - | 12.75 | 12.75 | 12.75 | 17.93 | 44.75 | Upgrade
|
| PS Ratio | 6.16 | 4.05 | 4.28 | 4.26 | 5.19 | 13.47 | Upgrade
|
| PB Ratio | 3.11 | 2.09 | 2.17 | 2.09 | 3.07 | 7.71 | Upgrade
|
| P/TBV Ratio | 3.20 | 2.15 | 2.27 | 2.20 | 3.22 | 8.46 | Upgrade
|
| P/FCF Ratio | 21.87 | 14.39 | 15.71 | 25.31 | - | - | Upgrade
|
| P/OCF Ratio | 19.52 | 12.77 | 13.92 | 15.59 | 37.87 | 162.35 | Upgrade
|
| EV/Sales Ratio | 4.83 | 2.81 | 3.15 | 3.33 | 4.31 | 12.84 | Upgrade
|
| EV/EBITDA Ratio | 14.82 | 8.55 | 9.44 | 11.05 | 28.00 | - | Upgrade
|
| EV/EBIT Ratio | 17.57 | 10.13 | 11.33 | 13.05 | 38.14 | - | Upgrade
|
| EV/FCF Ratio | 17.14 | 9.97 | 11.55 | 19.79 | - | - | Upgrade
|
| Debt / Equity Ratio | 0 | 0.00 | 0 | 0.00 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | - | Upgrade
|
| Debt / FCF Ratio | 0.00 | 0.00 | 0.00 | 0.01 | - | - | Upgrade
|
| Asset Turnover | 0.49 | 0.50 | 0.49 | 0.46 | 0.52 | 0.51 | Upgrade
|
| Inventory Turnover | 1.25 | 1.19 | 1.20 | 1.25 | 1.33 | 1.31 | Upgrade
|
| Quick Ratio | 10.73 | 8.99 | 7.47 | 5.59 | 5.08 | 3.78 | Upgrade
|
| Current Ratio | 11.43 | 9.60 | 8.11 | 6.10 | 5.54 | 4.04 | Upgrade
|
| Return on Equity (ROE) | 13.96% | 14.30% | 14.01% | 13.31% | 7.10% | -5.20% | Upgrade
|
| Return on Assets (ROA) | 8.46% | 8.62% | 8.47% | 7.36% | 3.65% | -6.31% | Upgrade
|
| Return on Capital (ROIC) | 9.09% | 9.35% | 9.34% | 8.30% | 4.29% | -7.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.80% | 14.20% | 14.00% | 12.30% | 6.50% | - | Upgrade
|
| Earnings Yield | 4.33% | 6.61% | 6.16% | 6.21% | 2.25% | -0.61% | Upgrade
|
| FCF Yield | 4.57% | 6.95% | 6.37% | 3.95% | -0.40% | -0.78% | Upgrade
|
| Dividend Yield | 1.92% | 3.06% | 2.10% | 0.98% | 0.51% | 0.21% | Upgrade
|
| Payout Ratio | 28.69% | 29.33% | 13.20% | 10.25% | 21.84% | - | Upgrade
|
| Buyback Yield / Dilution | -1.06% | 0.01% | -0.16% | 0.05% | -5.16% | 0.34% | Upgrade
|
| Total Shareholder Return | 0.86% | 3.08% | 1.93% | 1.03% | -4.65% | 0.56% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.